HRSL started their Massachusetts presence at MBI in 2016 and grew their sales to the point where they secured an investment from Ampersand Capital, acquired a few companies and rebranded as StageBio. StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries.